Your browser doesn't support javascript.
loading
Early Onset Atherosclerotic Cardiovascular Disease.
Mousavi, Idine; Suffredini, John; Virani, Salim S; Ballantyne, Christie; Michos, Erin D; Misra, Arunima; Saeed, Anum; Jia, Xiaoming.
Afiliação
  • Mousavi I; Section of Cardiology, Department of Medicine, Baylor College of Medicine, Houston, TX, USA.
  • Suffredini J; Section of Cardiology, Department of Medicine, Baylor College of Medicine, Houston, TX, USA.
  • Virani SS; The Aga Khan University, Karachi, Pakistan; Baylor College of Medicine and Texas Heart Institute, Houston, TX, USA.
  • Ballantyne C; Section of Cardiology, Department of Medicine, Baylor College of Medicine, Houston, TX, USA.
  • Michos ED; Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
  • Misra A; Section of Cardiology, Department of Medicine, Baylor College of Medicine, Houston, TX, USA.
  • Saeed A; Section of Cardiology, Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, USA.
  • Jia X; Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Eur J Prev Cardiol ; 2024 Jul 23.
Article em En | MEDLINE | ID: mdl-39041374
ABSTRACT
Recent trends indicate a concerning increase in early-onset atherosclerotic cardiovascular disease (ASCVD) among younger individuals (age < 55 in men and <65 in women). These findings highlight the pathobiology of ASCVD as a disease process that begins early in life and underscores the need for more tailored screening methods and preventive strategies. Increasing attention has been placed on the growing burden of traditional cardiometabolic risk factors in young individuals while also recognizing unique factors that mediate risk of premature atherosclerosis in this demographic such as substance use, socioeconomic disparities, adverse pregnancy outcomes, and chronic inflammatory states that contribute to the increasing incidence of early ASCVD. Additionally, mounting evidence has pointed out significant disparities in the diagnosis and management of early ASCVD and cardiovascular outcomes based on sex and race. Moving toward a more personalized approach, emerging data and technological developments using diverse tools such as polygenic risk scores and coronary artery calcium scans have shown potential in earlier detection of ASCVD risk. Thus, we review current evidence on causal risk factors that drive the increase in early ASCVD and highlight emerging tools to improve ASCVD risk assessment in young individuals.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Eur J Prev Cardiol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Eur J Prev Cardiol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos